AI-generated analysis. Always verify with the original filing.
This filing is the Annual Report on Form 40-F for BioHarvest Sciences Inc. (BHST) for the fiscal year ended December 31, 2025. As a Canadian issuer registered on the NASDAQ Stock Market, the company utilizes Form 40-F to satisfy its reporting obligations under the Securities Exchange Act of 1934. The filing confirms the company's continued operations and listing compliance, reporting 22,666,842 common shares issued and outstanding as of the fiscal year-end. The document encompasses the Annual Information Form and Audited Annual Financial Statements. The XBRL structured data embedded within the filing indicates comprehensive financial reporting across multiple categories, including property, plant, and equipment (such as manufacturing facilities and technology equipment), various convertible loan instruments, and complex equity structures involving warrants and stock options. The data also details executive compensation, related party transactions involving the CEO, CFO, and Chairman, and segment reporting across geographic regions including Canada, Israel, and the United States. Revenue streams are identified as Products and CDMO Services. The filing reflects the company's financial activities and position for the 2025 fiscal year compared with the 2024 and 2023 periods.